Pierre Courteille
Corporate Officer/Principal bij ABIVAX
Vermogen: 16 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Pierre Courteille
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.
29
| Non-Profit Organization | Miscellaneous Commercial Services | 29 |
14
| Public Company | Pharmaceuticals: Other | 14 |
11
| Public Company | Medical Specialties | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Pierre Courteille via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
| SANOFI | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
LFB Biotechnologies SASU
 LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Biotechnology | Chief Executive Officer Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| RENOVARO INC. | Biotechnology | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Operating Officer | |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Director/Board Member Corporate Officer/Principal | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Founder Director of Finance/CFO Chairman | |
| THERADIAG | Medical Specialties | Chief Executive Officer Chairman Chief Executive Officer | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Debiovision, Inc.
 Debiovision, Inc. Medical SpecialtiesHealth Technology Part of Debiopharm International SA, Debiovision, Inc. is a Canadian company that develops drugs and pharmaceutical products. The company is based in Montréal, Canada. Debiovision is the result of an M & A transaction between Debiopharm International SA and H3 Pharma, Inc. as of March 01, 2005. | Medical Specialties | Chief Executive Officer | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| École Normale Supérieure | College/University | Doctorate Degree Graduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| ESCP Europe Campus Paris | College/University | Corporate Officer/Principal Undergraduate Degree | |
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Investment Managers | Founder Private Equity Analyst | |
Tc Land Expression SA
 Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Operating Officer | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| American Liver Foundation of Northern California | Director/Board Member | ||
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| CARMAT | Medical Specialties | Founder Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Founder Director/Board Member | |
| THERACLION | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Hemarina SA
 Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Biotechnology | Chairman Chief Executive Officer | |
| La Fondation pour la Recherche Médicale | Director/Board Member | ||
Institut Français Des Administrateurs
 Institut Français Des Administrateurs Miscellaneous Commercial ServicesCommercial Services Institut Français Des Administrateurs is a private company based in Paris, France. The French company promotes governance and develops leadership skills. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Children's Hospital Oakland Research Institute
 Children's Hospital Oakland Research Institute Hospital/Nursing ManagementHealth Services Children's Hospital Oakland Research Institute operates as a biomedical research institute of Children's Hospital and Research Center. The private company is based in Oakland, CA. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
| REVO BIOLOGICS INC | Biotechnology | Director/Board Member Director/Board Member | |
| Baruch S. Blumberg Institute | Corporate Officer/Principal | ||
| A.P. Giannini Foundation | Director/Board Member | ||
| CORETECH 5 | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
| AFFLUENT MEDICAL | Medical Specialties | Founder Chief Executive Officer | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Human Resources Officer | |
| Pangaea Global Aids | Director/Board Member | ||
| Pure Blue Diagnostics, Inc. | Director/Board Member | ||
Olgram SAS
 Olgram SAS Miscellaneous Commercial ServicesCommercial Services Olgram SAS provides scientific research and development services. The company is based in Brehan, France. The French company was founded by Hervé Balusson, Maryvonne Hiance, Karim Asehnoune, Pi Nyvall Collén, Pierre Rocheteau. Pierre Rocheteau has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder | |
Intrivo Diagnostics
 Intrivo Diagnostics Information Technology ServicesTechnology Services Intrivo Diagnostics is a healthcare technology company that provides population health and care solutions through a fully integrated digital health infrastructure. The private company is based in Santa Monica, CA. The CEOs of the company are Ron Gutman and Reeve Benaron. Intrivo is also helping with the fight against COVID-19 by offering at-home testing kits. | Information Technology Services | Director/Board Member | |
| Healthtech For Care | Corporate Officer/Principal Chairman | ||
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer Director/Board Member |
Statistieken
Internationaal
| Frankrijk | 34 |
| Verenigde Staten | 13 |
| Canada | 3 |
| Zwitserland | 2 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 4 |
| Miscellaneous | 2 |
Operationeel
| Director/Board Member | 203 |
| Chairman | 76 |
| Corporate Officer/Principal | 63 |
| Founder | 49 |
| Chief Executive Officer | 44 |
Sterkste connecties
| Insiders | |
|---|---|
| Philippe Pouletty | 51 |
| Marc M. P. de Garidel | 31 |
| Franck Lescure | 28 |
| Carol Brosgart | 25 |
| Marc Le Bozec | 16 |
| Michel Finance | 15 |
| Maryvonne Hiance | 15 |
| Cédric Moreau | 14 |
| June Lee | 14 |
| Loïc Maurel | 12 |
| Troy Ignelzi | 12 |
| Gilles Avenard | 11 |
| Renaud Vaillant | 10 |
| Marie-Claire Janailhac-Fritsch | 10 |
| Christian Béchon | 10 |
- Beurs
- Insiders
- Pierre Courteille
- Bedrijfsconnecties